MSI Financial Services’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$34K Buy
968
+830
+601% +$24.8K ﹤0.01% 2110
2016
Q3
$3K Sell
138
-10
-7% -$250 ﹤0.01% 3401
2016
Q2
$4K Sell
148
-221
-60% -$5.07K ﹤0.01% 3281
2016
Q1
$9K Buy
369
+177
+92% +$4.2K ﹤0.01% 2863
2015
Q4
$6K Buy
192
+59
+44% +$1.91K ﹤0.01% 3022
2015
Q3
$5K Buy
133
+22
+20% +$1.37K ﹤0.01% 2441
2015
Q2
$8K Hold
111
﹤0.01% 2266
2015
Q1
$6K Buy
+111
New +$5.29K ﹤0.01% 2381
2014
Q1
Sell
-1
Closed 2676
2013
Q4
$0 Buy
+1
New +$24 ﹤0.01% 2633

Other funds holding AMAG

MSI Financial Services's AMAG Position: Q4 2016 in Review

MSI Financial Services increased its AMAG Pharmaceuticals (AMAG) stake by 601% in Q4 2016, buying an estimated $24.8K and bringing the position to 968 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

MSI Financial Services first reported a position in AMAG in Q4 2013 and has held it in 9 quarters since. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • MSI Financial Services held 968 shares of AMAG Pharmaceuticals worth $34K as of Q4 2016.
  • MSI Financial Services bought 830 AMAG Pharmaceuticals shares in Q4 2016, an estimated $24.8K.
  • AMAG Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2110 holding.
  • MSI Financial Services first reported a position in AMAG Pharmaceuticals in Q4 2013 and has held it in 9 quarters since.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.